{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:18:01Z","timestamp":1788193081470,"version":"build-2803163510"},"reference-count":13,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ejhf\/xuag188","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:46:21Z","timestamp":1780055181000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond procedural success after TAVI: is multi-pillar heart failure therapy the next frontier?"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9840-7818","authenticated-orcid":false,"given":"Thorald","family":"Stolte","sequence":"first","affiliation":[{"name":"Clinic for Cardiology, University Hospital Basel, University of Basel , Petersgraben 4, Basel 4031 ,","place":["Switzerland"]},{"name":"Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel , Spitalstrasse 2, Basel 4056 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2173-5738","authenticated-orcid":false,"given":"Thomas","family":"Nestelberger","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology, University Hospital Basel, University of Basel , Petersgraben 4, Basel 4031 ,","place":["Switzerland"]},{"name":"Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel , Spitalstrasse 2, Basel 4056 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-549X","authenticated-orcid":false,"given":"Felix","family":"Mahfoud","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology, University Hospital Basel, University of Basel , Petersgraben 4, Basel 4031 ,","place":["Switzerland"]},{"name":"Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel , Spitalstrasse 2, Basel 4056 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026083111494080500_xuag188-B1","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026083111494080500_xuag188-B2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cjca.2018.11.016","article-title":"The relationship between heart-failure hospitalization and mortality in patients receiving transcatheter aortic valve replacement","volume":"35","author":"Nazzari","year":"2019","journal-title":"Can J Cardiol"},{"key":"2026083111494080500_xuag188-B3","doi-asserted-by":"publisher","DOI":"10.1093\/ejhf\/xuaf015","article-title":"Incidence and management of heart failure phenotypes in patients undergoing transcatheter aortic valve implantation","author":"Von Peter","year":"8, 2026","journal-title":"Eur J Heart Fail"},{"key":"2026083111494080500_xuag188-B4","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa2500366","article-title":"Dapagliflozin in patients undergoing transcatheter aortic-valve implantation","volume":"392","author":"Raposeiras-Roubin","year":"2025","journal-title":"N Engl J Med"},{"key":"2026083111494080500_xuag188-B5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026083111494080500_xuag188-B6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026083111494080500_xuag188-B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2026.200610","article-title":"Left ventricular systolic recovery after TAVI in severe aortic stenosis: a systematic review and meta-analysis","volume":"29","author":"Hasabo","year":"2026","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"2026083111494080500_xuag188-B8","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/s41591-022-01971-4","article-title":"Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER","volume":"28","author":"Jhund","year":"2022","journal-title":"Nat Med"},{"key":"2026083111494080500_xuag188-B9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/eurheartj\/ehab798","article-title":"Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J"},{"key":"2026083111494080500_xuag188-B10","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"2026083111494080500_xuag188-B11","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"2026083111494080500_xuag188-B12","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"2026083111494080500_xuag188-B13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMoa2410659","article-title":"Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes","volume":"393","author":"Agarwal","year":"2025","journal-title":"N Engl J Med"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag188\/70883413\/xuag188.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag188\/70883413\/xuag188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:50:28Z","timestamp":1788191428000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article\/doi\/10.1093\/ejhf\/xuag188\/8767158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.1093\/ejhf\/xuag188","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"xuag188"}}